FIRMAGON
Active Ingredient: DEGARELIX (DEGARELIX ACETATE)
Product Overview
About FIRMAGON
FIRMAGON is a medicine that contains the active ingredient DEGARELIX (DEGARELIX ACETATE), which is used in the treatment of hormone-sensitive prostate cancer. It works by reducing the production of testosterone, a hormone that can promote the growth of cancer cells. FIRMAGON is administered via injection and is typically used in adult men.
Key Benefits & Uses
- Treatment of hormone-sensitive prostate cancer
- Reduces the production of testosterone, slowing the growth of cancer cells
- Administered via injection, providing a convenient and effective treatment option
Active Ingredient & Action
DEGARELIX (DEGARELIX ACETATE) is a synthetic decapeptide and a gonadotropin-releasing hormone (GnRH) antagonist. It works by binding to GnRH receptors in the pituitary gland, reducing the production of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which in turn reduces the production of testosterone.
Important Notes
It is essential to follow the prescribed treatment plan and dosage instructions when using FIRMAGON. Patients should also be aware of potential side effects, such as hot flashes, injection site reactions, and changes in liver function. Regular monitoring by a healthcare professional is recommended to ensure safe and effective treatment.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.